- Collaboration. At Mayo Clinic, hematologists, oncologists, bone marrow transplant experts, radiation oncologists, pathologists and radiologists work as a multidisciplinary team to provide whole-person care for people with multiple myeloma. Other professionals are included as needed.
- Experience. Mayo Clinic doctors have extensive experience diagnosing and treating multiple myeloma. Each year, Mayo Clinic doctors care for more than 2,800 people with multiple myeloma.
- Expertise. Mayo Clinic myeloma experts are respected for their expertise in diagnosing and treating myeloma. Your care team is prepared with the knowledge and resources to provide you exactly the care you need.
- Innovative approach to myeloma. Mayo Clinic doctors developed the Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) model to classify myeloma as high-risk, intermediate-risk or standard-risk myeloma. The mSMART risk level of your melanoma helps determine your prognosis and helps your doctor select the treatment options that offer you the greatest benefit.
Access to the latest. Mayo Clinic doctors have access to the latest diagnosis and treatment options, such as specialized laboratory testing to analyze myeloma cells for abnormalities that may suggest the best treatment option.
Mayo Clinic researchers are studying cutting-edge treatments, such as immunotherapy treatments that use the body's immune system to fight cancer. Mayo Clinic researchers were the first to report success against multiple myeloma using an engineered measles virus.
- Exactly the care you need. Mayo Clinic's risk-adapted therapy approach to myeloma treatment means your treatment options are tailored to your needs.
- Latest research. A leader in multiple myeloma research, Mayo Clinic played a key role in developing new diagnostic techniques and drug treatments for multiple myeloma. Mayo researchers continue to focus on developing new treatments.
- Comprehensive cancer center. The Mayo Clinic Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center — a recognition for an institution's scientific excellence in research and multispecialty resources that are focused on cancer prevention, diagnosis and treatment.
Mayo Clinic in Rochester, Minn., Mayo Clinic in Jacksonville, Fla., and Mayo Clinic in Scottsdale, Ariz., are ranked among the Best Hospitals for cancer by U.S. News & World Report.
Mayo Clinic: Answers you can trust
At Mayo Clinic, we assemble a team of specialists who take the time to listen and thoroughly understand your health issues and concerns. We tailor the care you receive to your personal health care needs. You can trust our specialists to collaborate and offer you the best possible outcomes, safety and service.
Mayo Clinic is a not-for-profit medical institution that reinvests all earnings into improving medical practice, research and education. We're constantly involved in innovation and medical research, finding solutions to improve your care and quality of life. Your doctor or someone on your medical team is likely involved in research related to your condition.
Our patients tell us that the quality of their interactions, our attention to detail and the efficiency of their visits mean health care — and trusted answers — like they've never experienced.
Why Choose Mayo Clinic
What Sets Mayo Clinic Apart
Sept. 11, 2014
- Lichtman MA, et al. Williams Hematology. 8th ed. New York, N.Y.: The McGraw-Hill Companies; 2010. http://www.accessmedicine.com/resourceTOC.aspx?resourceID=69. Accessed June 24, 2014.
- Ferri FF. Ferri's Clinical Advisor 2014: 5 Books in 1. Philadelphia, Pa.: Mosby Elsevier; 2014. https://www.clinicalkey.com. Accessed June 24, 2014.
- Niederhuber JE, et al., eds. Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. http://www.clinicalkey.com. Accessed June 24, 2014.
- Multiple myeloma. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed
- Plasma cell neoplasms (including multiple myeloma) treatment (PDQ). National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/treatment/myeloma/Patient. Accessed June 24, 2014.
- Palumbo A, et al. International Myeloma Working Group consensus statement for the management, treatment and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation. Journal of Clinical Oncology. 2014;32:587.
- Kyprolis (prescribing information). South San Francisco, Calif.: Onyx Pharmaceuticals, Inc.; 2012. http://www.kyproslis.com. Accessed June 24, 2014.
- Velcade (prescribing information). Cambridge, Mass.: Millennium Pharmaceuticals, Inc.; 2012. http://www.velcade.com. Accessed June 24, 2014.
- Integrative medicine and complementary and alternative therapies as part of blood cancer care. The Leukemia & Lymphoma Society. http://www.lls.org/#/resourcecenter/freeeducationmaterials/treatment/integrativemedandcam. Accessed June 24, 2014.
- Cook AJ. Decision Support System. Mayo Clinic, Rochester, Minn. May 2, 2014.
- Russell SJ, et al. Remission of disseminated cancer after system oncolytic virotherapy. Mayo Clinic Proceedings. 2014;89:926.